Biotech grants in the United Kingdom

Open

Funds Wales-based businesses of all sizes to research and develop new products, processes, or services through discretionary Welsh Government R&D grants.

Open

Funds collaborative R&D between Wales-based businesses and knowledge-base partners, with the Welsh Government covering 100% of the academic or research partner's eligible costs.

Open

Supports small businesses in Northern Ireland with proof-of-concept development for testing commercialization hypotheses.

Open

Supports United Kingdom researchers connecting globally through partnerships in planet, health, technology, and talent priorities via UKRI International Science Partnerships Fund.

Open

Funds early-stage university-linked science ventures through philanthropic capital to strengthen real-world implementation.

Open

Funds long-run capital for Cambridge-affiliated deep-tech and life science spinouts.

Open

Funds tri jurisdiction collaboration between the United States, Republic of Ireland, and Northern Ireland through a science and technology partnership.

Open

Supports University of Warwick researchers with internal proof-of-concept funding so registered discoveries can move toward commercialization.

Open

Supports underrepresented United Kingdom researchers through focused fellowships and research development pathways.

Open

Funds established United Kingdom investigators in bold health research with long-term flexible scientific support.

Open

Connects West Midlands teams to United Kingdom Innovate competitions in health technology, clean technology, and advanced manufacturing innovation.

Open

Offers UCL Business translational funding for teams turning research into market pilots.

Between cycles

Supports United Kingdom non-academic organisations in developing independent innovation programmes through UKRI Future Leaders Industry fellowships.

Between cycles

Supports United Kingdom life science manufacturing teams through LSIMF grants for facility and process innovation.

Between cycles

Contracts UK or EU organisations to implement and independently evaluate mature cancer innovations across NHS sites in England.

Between cycles

Funds core Parkinson's science projects led from the United Kingdom across biological and clinical research questions.

Between cycles

Funds training of clinical researchers in acute care science to strengthen real-world implementation.

Between cycles

Funds translational Parkinson's drug discovery in the United Kingdom to generate partnership-ready preclinical evidence.

Between cycles

Supports high-throughput small molecule discovery for faster medicine development and health impact.

Between cycles

Funds milestone-based cardiovascular technologies toward translation to strengthen real-world implementation.

Between cycles

Funds doctoral cardiovascular research positions focused on discovery innovation to strengthen real-world implementation.

Between cycles

Funds senior cardiovascular scientists to build independent research teams to strengthen real-world implementation.

Between cycles

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

Between cycles

Funds academic Alzheimer's researchers with hit-to-lead and development-stage support plus therapeutic guidance.